...

Omics Studio

AI tool that helps omics researchers save months connecting data, freeing up time to curing illnesses.

Active Next round Seed Denmark AI

Omics is an incredibly important field of pre-clinical research. By allowing us to monitor biology on a molecular level, it holds vital keys to curing many of the most challenging illnesses we face. As technology evolves, so does the complexity of the data available, making data integration and analysis a significant challenge. Omics Studio addresses this major issue in pre-clinical research.
Currently, researchers spend months of valuable time connecting data points from bioinformatic databases and literature. Omics Studio makes this information available in seconds, in a format that reduces repetitive tasks, allowing time and money to be directed toward actual discovery processes for diagnosis and treatment.
Omics Studio will transform researchers’ interactions with omics data, enabling seamless biomarker, drug, and biological system discovery, uncovering new connections, and mapping and comparing pathways.

Last updated November 13, 2024

Founding team

..

Kenneth Kastaniegaard, CEO

Kenneth has a PhD from Aalborg University along with a role as research assistant. He is a researcher, and has worked as such, before he co-founded Biogenity, also as the CEO.

..

Louis Loeb, CCO

Along with fellow co-founder Kenneth Kastaniegaard, Louis also co-founded Biogenity in the same role. As his fellow co-founders, is also a graduate of Aalborg University.

..

Patrick Østergaard, CTO

software developer with experience in both independent development, business operations, and customer communications. He has developed a Steam-available computer game before co-founding Omics Studio.

...

Established: 2024

Investment: 2024

Money raised: €296.000

Soft funding: €102.000

Our investment thesis

This has the potential to radically change the way scientists (especially non data scientists) work in these companies allowing for massive cost savings as the preparatory work leading to clinical trials can be vastly improved.

Related